Will genomics revolutionise pharmaceutical R&D?

Author： Noble D.  

Publisher： Elsevier

ISSN： 0167-7799

Source： Trends in Biotechnology, Vol.21, Iss.8, 2003-08, pp. : 333-337

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rethinking innovation in pharmaceutical R&D

By Baker Ann   Gill Jasween  

Journal of Commercial Biotechnology, Vol. 12, Iss. 1, 2005-10 ,pp. : 45-49

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

Impact of the life sciences on organisation and management of R&D in large pharmaceutical firms

By Mittra James  

International Journal of Biotechnology, Vol. 10, Iss. 5, 2008-11 ,pp. : 416-440

Inderscience Publishers

Access to resources Recommend Favorite

Biotechnology and pharmaceutical R&D and licensing trends: You pays your money and takes your chances

By Ratliff Alan  

Journal of Commercial Biotechnology, Vol. 10, Iss. 1, 2003-09 ,pp. : 54-59

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

Competitive biomedical R&D?

By Sussman P.N.  

Trends in Biotechnology, Vol. 16, Iss. 12, 1998-12 ,pp. : 528-528

Elsevier

Access to resources Recommend Favorite

Biotech Alliances: Bridging the R&D Gap

By Scott Nerida  

Journal of Commercial Biotechnology, Vol. 10, Iss. 1, 2003-09 ,pp. : 107-108

Palgrave Macmillan Ltd

Access to resources Recommend Favorite